行情

INSM

INSM

Insmed
NASDAQ

实时行情|Nasdaq Last Sale

29.51
+2.73
+10.19%
已收盘, 17:46 08/06 EDT
开盘
29.77
昨收
26.78
最高
29.92
最低
27.63
成交量
167.98万
成交额
--
52周最高
34.94
52周最低
12.09
市值
29.81亿
市盈率(TTM)
-10.4493
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测INSM价格均价为44.38,最高价位56.00,最低价为34.00。

EPS

INSM 新闻

更多
Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates
Insmed (INSM) delivered earnings and revenue surprises of -10.34% and 16.58%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 19小时前
Insmed Reports Second Quarter 2020 Financial Results and Provides Business Update
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the second quarter ended June 30, 2020, and provided a business update.
PR Newswire · 22小时前
Did Hedge Funds Make The Right Call On Insmed Incorporated (INSM)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional invest
Insider Monkey · 3天前
Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
Insmed (INSM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/30 16:33
OSI Systems Receives $5 Million Order to Provide Medical Sensors
OSI Systems, Inc. (the "Company" or "OSI Systems") (NASDAQ: OSIS) today announced that its Optoelectronics division has received an order for approximately $5 million from a leading healthcare original equipment manufacturer (OEM) to provide optical sensors fo
Business Wire · 07/28 12:30
OSI Systems Awarded $5 Million Contract to Develop Automated Detection of Biosecurity Risk Items
OSI Systems, Inc. (the "Company" or "OSI Systems") (NASDAQ: OSIS) today announced that its Security division was awarded a contract from the Commonwealth Government of Australia represented through the Department of Agriculture, Water and the Environment ("DAW
Business Wire · 07/27 12:30
Insmed to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 6, 2020
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its second quarter 2020 financial results on Thursday, August 6, 2020.
PR Newswire · 07/27 12:00
Insmed shares are trading higher after the company's lung infection treatment received a positive opinion from the European Medicines Agency.
Benzinga · 07/24 14:00

所属板块

生物技术和医学研究
-0.96%
制药与医学研究
-0.46%

热门股票

代码
价格
涨跌幅

INSM 简况

Insmed Incorporated是一家全球性的生物制药公司。该公司的产品阿米卡星脂质体吸入悬浮液(ARIKAYCE)开发用于治疗鸟分枝杆菌复合体(MAC)肺病,作为成人患者联合抗菌药物治疗方案的一部分,是一种必须或可选择的治疗方案。该公司的早期临床管道包括INS1007,一种新的口服可逆抑制剂二肽基肽酶1,具有治疗非囊性纤维化支气管扩张和其他炎性疾病的潜力.该公司还生产INS1009,一种吸入制剂的曲前列环素前药,提供差异化的产品特征,用于治疗包括肺动脉高压的罕见肺部疾病。
展开

微牛提供Insmed Incorporated(NASDAQ-INSM)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的INSM股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易INSM股票基本功能。